Guest guest Posted July 5, 2008 Report Share Posted July 5, 2008 Recently published news shows that researchers from the University of Michigan recently conducted a clinical study to evaluate the potential role of the LYN kinase, a protein structure that is implicated in some aspects of cellular growth. LYN kinase is thought to regulate survival and responsiveness in some CML cells. This may provide insight into why some patients do not respond to Gleevec while others experience significant and long-term responses ..http://www.caring4cancer.com/go/cancer/news?NewsItemId=42251 Blessings, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.